Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2438_57
Abstract: vs 10.7%, p = 0.18) GVHD were also comparable as well as 2‐year GVHD free/relapse‐free survival (FB2: 44.4% vs 42.8%, p = 0.38). In multivariate analysis, there was a trend for worse outcome using FB3/FB4…
read more here.
Keywords:
chemotherapy hepatitis;
direct acting;
antivirals immuno;
hepatitis virus ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2021.107606
Abstract: Patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) have a poor prognosis. This study investigated the efficacy of rituximab-containing immuno-chemotherapy regimens for EBV-HLH. In this study, 15 patients were treated with rituximab-containing regimens. The treatment efficacy…
read more here.
Keywords:
ebv hlh;
containing immuno;
immuno chemotherapy;
rituximab containing ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Biomacromolecules"
DOI: 10.1021/acs.biomac.9b00788
Abstract: Currently, immuno-chemotherapy based on tumor-associated macrophages (TAMs) is mainly used for elimination of M2 macrophages. However, these methods cannot make full use of the positive immune-modulatory effects of macrophages. This study explores a two-way cruise…
read more here.
Keywords:
chemotherapy;
two way;
way cruise;
immuno chemotherapy ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "European Journal of Haematology"
DOI: 10.1111/ejh.13486
Abstract: Current UK standard of care in frontline advanced stage (III or IV) symptomatic follicular lymphoma (FL) is immuno-chemotherapy with anti-CD20 monoclonal antibodies (mAbs) rituximab (R) or obinutuzumab (O), in combination with cyclophosphamide, vincristine and prednisolone…
read more here.
Keywords:
efficacy infection;
immuno chemotherapy;
follicular lymphoma;
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.tps4139
Abstract: TPS4139Background: Peri-operative chemotherapy with 5FU, oxaliplatin and docetaxel (FLOT) is a new standard of care in resectable gastro-oesophageal adenocarcinoma (GOA), however with 3y survival r...
read more here.
Keywords:
peri operative;
iconic peri;
peri;
operative immuno ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2023.1028202
Abstract: Introduction Many randomized controlled trials have indicated that immuno-chemotherapy could generate clinical benefits, though the cost of immuno-chemotherapy was so prohibitive and the options were varied. This investigation aimed at evaluating effectiveness, safety, and cost-effectiveness…
read more here.
Keywords:
plus chemotherapy;
cost;
first line;
analysis ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
3
Published in 2022 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.843987
Abstract: Background Stage III Non-small cell lung cancer (NSCLC) is a heterogenous disease with novel treatment options. Recently, immunotherapy has attracted a lot of attention for advanced NSCLC. Objective The objective of our study was to…
read more here.
Keywords:
stage iii;
immuno chemotherapy;
neoadjuvant immuno;
stage ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15092476
Abstract: Simple Summary Surgical resections remain the gold standard for early stages non-small-cell carcinoma (NSCLC) and may be considered for locally advanced tumors. Medical treatment has changed drastically in recent years, especially for advanced stages, for…
read more here.
Keywords:
non small;
immunotherapy;
small cell;
immuno chemotherapy ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12020285
Abstract: Hepatitis B virus reactivation (HBVr) can develop in HBV surface antigen (HBsAg) positive or HBsAg-negative and anti-hepatitis B core antigen antibodies (anti-HBc) positive (past HBV infection) patients receiving immuno-chemotherapy for hematological malignancies. A higher rate…
read more here.
Keywords:
chemotherapy;
immuno chemotherapy;
non hodgkin;
infection ... See more keywords